A detailed history of Founders Financial Securities LLC transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Founders Financial Securities LLC holds 124,000 shares of DARE stock, worth $42,160. This represents 0.01% of its overall portfolio holdings.

Number of Shares
124,000
Previous 124,000 -0.0%
Holding current value
$42,160
Previous $38,000 57.89%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 17, 2023

BUY
$0.46 - $0.91 $4,600 - $9,100
10,000 Added 8.77%
124,000 $57,000
Q4 2022

Feb 08, 2023

SELL
$0.82 - $1.03 $191,735 - $240,838
-233,824 Reduced 67.22%
114,000 $94,000
Q3 2022

Oct 27, 2022

BUY
$1.04 - $1.27 $254,096 - $310,291
244,324 Added 236.06%
347,824 $5.27 Million
Q2 2022

Jul 27, 2022

BUY
$0.94 - $1.76 $97,290 - $182,160
103,500 New
103,500 $127,000
Q1 2022

May 13, 2022

SELL
$1.42 - $2.09 $146,970 - $216,314
-103,500 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.42 - $2.13 $7,100 - $10,650
5,000 Added 5.08%
103,500 $207,000
Q2 2021

Aug 16, 2021

BUY
$1.21 - $1.89 $58,685 - $91,665
48,500 Added 97.0%
98,500 $186,000
Q3 2020

Nov 16, 2020

SELL
$0.98 - $1.52 $46,550 - $72,200
-47,500 Reduced 48.72%
50,000 $50,000
Q2 2020

Aug 12, 2020

BUY
$0.84 - $1.11 $65,100 - $86,025
77,500 Added 387.5%
97,500 $102,000
Q1 2020

May 14, 2020

BUY
$0.79 - $1.7 $15,800 - $34,000
20,000 New
20,000 $17,000
Q4 2019

Feb 11, 2020

SELL
$0.72 - $0.9 $14,400 - $18,000
-20,000 Closed
0 $0
Q2 2019

Jul 22, 2019

BUY
$0.79 - $1.66 $15,800 - $33,200
20,000 New
20,000 $17,000

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $28.8M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track This Portfolio

Track Founders Financial Securities LLC Portfolio

Follow Founders Financial Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.